SCHEMBL5237121

SCHEMBL5237121

CCOC(=O)c1c(-c2cccc(C)n2)nn2cccc(S(C)(=O)=O)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 4/20 0.41
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
PDE4D Q08499 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
CYP1A2 P05177 1/20 0.35
TP53 P04637 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ADORA3 P0DMS8 2/20 0.34
ADORA2B P29275 1/20 0.34
MAPK1 P28482 1/20 0.34
GAA P10253 1/20 0.34
EGFR P00533 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5235429 0.82 ALDH1A1 (0.44) TGFBR1KDM4EALDH1A1PDE4DL3MBTL1
SCHEMBL4865701 0.78 EGFR (0.55) TGFBR1KDM4EALDH1A1PDE4DCA12
SCHEMBL5234607 0.78 TGFBR1 (0.43) TGFBR1KDM4EALDH1A1CA12CA1
SCHEMBL4868672 0.71 TGFBR1 (0.49) TGFBR1KDM4EALDH1A1L3MBTL1CYP1A2
SCHEMBL5232777 0.70 TGFBR1 (0.46) TGFBR1KDM4EALDH1A1L3MBTL1CYP1A2
SCHEMBL5236967 0.68 TGFBR1 (0.55) TGFBR1THRB
SCHEMBL5231391 0.68 EGFR (0.53) TGFBR1KDM4EALDH1A1PDE4DCA12
SCHEMBL5231066 0.68 TGFBR1 (0.41) TGFBR1CYP1A2
SCHEMBL28467069 0.66 PDE4D (0.45) KDM4EALDH1A1PDE4DCA12CA1
SCHEMBL38663185 0.65 PDE4D (0.53) KDM4EALDH1A1PDE4DCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1543001-B1 PYRAZOLOPYRIDINE DERIVATIVES AS TGF BETA SIGNAL TRANSDUCTION INHIBITORS FOR THE TREATMENT OF CANCER LILLY CO ELI (US) 2007-08-15 EP disclosed